Beijing Cellular Therapy Forum and Clinical Research Management Training International Conference

All day
University of Chicago Center in Beijing
20th Floor, Culture Plaza
59A Zhong Guan Cun Street
Haidian District, Beijing

May
18

Organizers:

Beijing Medical Association Society of Oncology

University of Chicago Center in Beijing

Zhongguancun Jiutai Good Clinical Practice Union

Beijing Hospital

 

Assistant Organizers:

Zhongguancun Jiutai Good Clinical Practice Union Cellular Biologics Clinical Trial Committee

Apexell Medicine Research (Beijing) Co.,Ltd

 

About the Conference

Stem cell transplant is one of the most distinguished scientific developments in the 20th century; representing an important milestone for the treatment of hematologic malignancies. The Beijing transplant regimen as well as John Hopkin post-transplant cyclophosphamide regimen using haploidentical donors expands the donor options providing potential cure to many patients with hematologic malignancies. As one of the top medical centers in USA, University of Chicago Medical Center (UCMC) contributed haplo-cord stem cell transplant regimen to the transplant field, the Cellular Therapy program at UCMC has been among the first centers to offer the two commercially available CART products to patients in the Chicago area. Currently, the program has many cellular therapy clinical trials ongoing to treat lymphoma, multiple myeloma, acute leukemia and various solid tumors. This meeting invited many leading Chinese scientists and hematologist/oncologists in the field of cellular therapy and cancer treatment to share academic ideas and promote international collaboration between the Chinese investigators and the faculties at UCMC. All the colleagues who are interested in cellular and immunotherapy are welcome to attend the meeting.

 

Agenda

Saturday morning, May 18th / 5月18日上午

Main Conference Venue / 主会场

(Simultaneous Translation will be provided /提供中英文同声传译)

7:30-8:30

Registration

8:30-8:40

Opening Remarks

Jie Ma, Beijing Hospital 

Hongtao Liu, Section of Hematology / Oncology, UChicago Medicine

8:40-9:10

Haploidentical Transplantation: Some Concept, Different Results

Xiaojun Huang, Chairman, Peking University Institute of Hematology、 Director, Department of Hematology, Peking University People’s Hospital

9:10-9:40

The Past, Current and the Future of Stem Cell Transplant and Cellular Therapy

Michael Bishop, Section of Hematology / Oncology, UChicago Medicine

9:40-10:10

State-of-the Art of Treatment of ALL: Molecular, Antibody and Cellular Targeting to Eradicate MRD ALL

MRD Wendy Stock, Section of Hematology / Oncology, UChicago Medicine

10:10-10:30

Discussion

10:30-10:40

Tea Break

10:40-11:10

Immunotherapy for Renal Cell Carcinoma

Kan Gong, Peking University First Hospital

11:10-11:40

Clinical Study in Cellular Immunotherapy for Solid Tumors

Jie Ma, Beijing Hospital

11:40-12:10

Progress in Immunotherapy for Prostate Cancer

Wei Wang, Beijing Tongren Hospital 

12:10-12:30

Discussion

12:30-13:30

Lunch (For all participants) 

 

Saturday afternoon, May 18th(Main Conference Place)

Breakout Session I: Hematology

(Simultaneous Translation will be provided /提供中英文同声传译)

13:30-13:40

Opening Remarks

13:40-14:10

Donor-derived HCMV-specific T Cells Therapy for CMV Infection Post Allogenic Stem Cell

Xiangyu Zhao, Section of Hematology /Peking University Institute of Hematology

14:10-14:40

Checkpoint Blockade Therapy for Lymphoma

Justin Kline, Section of Hematology/Oncology (Cancer) UChicago Medicine

14:40-15:10

Road to Improve the Outcomes of AML with Poor Gene Mutation-experience from A Single Center

Daihong Liu, Section of Hematology, Chinese PLA General Hospital (PLA 301 Hospital) 

15:10-15:30

Discussion

15:30-15:40

Tea Break 

15:40-16:10

Immunotherapies in Hematologic Malignancies

Hongtao Liu, Section of Hematology / Oncology, UChicago Medicine 

16:10-16:40

CD19CAR-T for Treatment of B cell ALL Chinese Experience

Peihua Lu, Institute of Hematology, Lu Daopei Hospital

16:40-17:10

The CART Treatment for Lymphomas

Peter Riedell, Section of Hematology / Oncology UChicago Medicine

17:10-17:30

Discussion

 

Saturday afternoon, May 18th(Large Classroom)

Breakout Session II: Urology

13:30-13:40

Opening Remark

Kan Gong, Peking University First Hospital

13:40-14:10

Experience in Immunotherapy of Urinary Tumors

Haixing Mai, PLA Fifth Medical Center

14:10-14:40

Application of PSMA-PET in the Diagnosis and Treatment of Prostate Cancer

Ning Zhang, Beijing Cancer Hospital, Peking University

14:40-15:10

Discussion

15:10-15:20

Tea Break

15:20-15:50

Application of Immunotherapy for Urothelial Carcinoma

Gangyue Hao, Beijing Friendship Hospital

15:50-16:20

Management of Adverse Immune Reactions

Xinrong Fan, Peking Union Medical College Hospital

16:20-16:50

Discussion

16:50-17:20

Conclusion

Xin Ma , Chinese PLA General Hospital (PLA 301 Hospital)

 

Saturday afternoon, May 18th(Lecture Hall)

Breakout Session III: Clinical Research Management Training

13:30-13:40

Opening Remarks

13:40-14:25

Principles and Design of Cellular Immunotherapy of Cancer

Weidong Han, Chinese PLA General Hospital (PLA 301 Hospital)

14:25-15:10

Clinical Trial Design for Cellular Therapy 

Yi Zhang, The First Affiliated Hospital of Zhengzhou University

15:10-15:20

Tea Break

15:20-16:05

Thinking and Practice of Solid Tumor Immunotherapy

Jiuwei Cui, The First Affiliated Hospital of Jilin University

16:05-16:50

Process Control and Common Problems in Clinical Trials

Kexin Li, Beijing Hospital

16:50-17:35

Quality Standard of Clinical Viral Vectors

M. Jaysson Eicholtz, Apexell Medicine